What are the recommended nebulized doses of Duolin (salbutamol + ipratropium) and inhaled Budecort (beclomethasone) for a 13-year-old child weighing 33 kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Nebulized Duolin and Budecort Dosing for 13-Year-Old, 33 kg

For a 13-year-old weighing 33 kg with acute asthma exacerbation, administer nebulized Duolin (salbutamol + ipratropium) 1.5-3.0 mL every 20 minutes for 3 doses, then as needed, combined with nebulized budesonide 2 mg (4 mL) as a single dose immediately after the first bronchodilator treatment 1, 2.

Acute Exacerbation Management

Bronchodilator Therapy (Duolin)

  • Dosing: 1.5-3.0 mL nebulized every 20 minutes for 3 doses, then hourly for 2 hours as needed 1
  • This combination (salbutamol + ipratropium) provides superior bronchodilation compared to salbutamol alone, with 32% greater improvement in peak flow at 60 minutes 3
  • The combination is particularly beneficial in severe exacerbations, reducing hospitalization rates from 73% to 39% in the most severe cases 4

Inhaled Corticosteroid (Budecort)

  • Dosing: 2 mg (4 mL) nebulized as a single dose immediately after the first bronchodilator nebulization 2
  • This provides rapid additional benefit when added to standard treatment, with significant improvements in PEFR, respiratory rate, pulse rate, and oxygen saturation at 1,2, and 3 hours 2
  • The immediate effect of nebulized budesonide added to standard bronchodilator therapy is well-documented in pediatric patients aged 5-15 years 2

Long-Term Controller Therapy Considerations

For ongoing asthma management after the acute episode resolves, this 13-year-old falls into the age category where either daily low-dose inhaled corticosteroid with as-needed SABA OR as-needed ICS and SABA used concomitantly (intermittent dosing) are both acceptable options for mild persistent asthma 5.

Intermittent ICS Approach (if appropriate)

  • 2-4 puffs of albuterol followed by 80-250 μg beclomethasone equivalent every 4 hours as needed for symptoms 5
  • This approach requires good symptom perception and patient reliability
  • Not appropriate for patients with poor symptom awareness 5

Important Caveats

Cardiac Safety: Despite concerns about tachycardia with salbutamol, standard dosing (2.5 mg) does not significantly affect heart rate, and arrhythmia incidence is similar to placebo even in high-risk populations 6. Treatment should not be withheld due to baseline tachycardia or underlying heart disease at standard doses.

Systemic Corticosteroids: If this is a moderate-to-severe exacerbation requiring emergency care, add oral prednisolone 1-2 mg/kg/day (maximum 60 mg/day) in divided doses 1, 2. For this 33 kg patient, that would be 33-66 mg daily.

Delivery Efficiency: Be aware that only 5-25% of the prescribed nebulized dose actually reaches the lungs depending on formulation 7, but the doses recommended above account for this.

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.